Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Chen, KY, Dahdah, N, Maurice, RL, Miller, J, Curtis, N, Cheung, M, Burgner, D.
Abstract 157: Functional and Structural Intermediate Vascular Phenotypes Relating to Long-Term Cardiovascular Risk in Kawasaki Disease.
Circulation
131(suppl_2)
:
2015
view publication
Kim, J, Shimizu, C, Yang, H, Harismendy, O, Truong Hoang, L, Levy, E, Cimaz, R, Burgner, D, Yeung, RS, Khor, CC, et al.
Abstract O.17: Whole Genome Sequencing of a six-member African American family with two Kawasaki disease-affected siblings identifies novel susceptibility variants.
Circulation
131(suppl_2)
:
2015
view publication
Burgner, DP, Sabin, MA, Magnussen, CG, Cheung, M, Sun, C, Kähönen, M, Hutri-Kähönen, N, Lehtimäki, T, Jokinen, E, Laitinen, T, et al.
Early childhood hospitalisation with infection and subclinical atherosclerosis in adulthood: the Cardiovascular Risk in Young Finns Study..
Atherosclerosis
239(2)
:
496 -502
2015
view publication
Juonala, M, Voipio, A, Pahkala, K, Viikari, JSA, Mikkilä, V, Kähönen, M, Hutri-Kähönen, N, Jula, A, Burgner, D, Sabin, MA, et al.
Childhood 25-OH vitamin D levels and carotid intima-media thickness in adulthood: the cardiovascular risk in young Finns study..
J Clin Endocrinol Metab
100(4)
:
1469 -1476
2015
view publication
Collier, FM, Tang, MLK, Martino, D, Saffery, R, Carlin, J, Jachno, K, Ranganathan, S, Burgner, D, Allen, KJ, Vuillermin, P, et al.
The ontogeny of naïve and regulatory CD4(+) T-cell subsets during the first postnatal year: a cohort study..
Clin Transl Immunology
4(3)
:
e34
2015
view publication